Patents by Inventor Eric Bacqué

Eric Bacqué has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7119115
    Abstract: The present invention relates to novel compounds derived from indazoles or indoles of formula (1) or formula (2), to methods for treating tumors or cancerous cells with compounds of formula (1) or formula (2) and to pharmacaetutical compositions comprising a pharmaceutically acceptable carrier and a compound of formula (1) or formula (2)
    Type: Grant
    Filed: January 21, 2004
    Date of Patent: October 10, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Michel Tabart, Eric Bacqué, Sylvie Wentzler, Cécile Combeau, Conception Nemecek, Patrick Mailliet, Fabienne Thompson
  • Patent number: 6903217
    Abstract: Heterocyclylalkylpiperidine derivatives of general formula (I) in their enantiomeric or diastereoisomeric forms or mixtures of these forms, and/or, where appropriate, in their syn or anti form or a mixture thereof, as well as any salt thereof.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: June 7, 2005
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacqué , Jean-Christophe Carry, Youssef El-Ahmad, Michel Evers, Philippe Hubert, Jean-Luc Malleron, Serge Mignani, Guy Pantel, Michel Tabart, Fabrice Viviani
  • Patent number: 6878820
    Abstract: The present invention relates to group A streptogramin derivatives of general formula (I) and processes for preparing the same: which has particularly advantageous antibacterial activity.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: April 12, 2005
    Assignee: Aventis Pharma S. A.
    Inventors: Eric Bacqué , Françoise Tetot, Gérard Puchault, Jean-Claude Barrière
  • Patent number: 6841562
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) in which R1a is hydrogen, halogen, hydroxyl, amino, alkylamino, dialkylamino, hydroxyamino, alkoxyamino or alkylalkoxyamino and R1b is hydrogen, or R1a and R1b form an oxo, R2 is carboxyl, carboxymethyl or hydroxymethyl, R3 is alkyl either substituted with phenylthio optionally substituted with halogen, hydroxyl, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, carboxyl, alkoxycarbonyl, cyano or amino, or with cycloalkylthio (3 to 7 members) optionally substituted with halogen or trifluoromethyl, or with heteroarylthio (5 to 6 members and 1 to 4 heteroatoms chosen from N, O and S), optionally substituted with halogen, hydroxyl, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, carboxyl, alkoxycarbonyl, cyano or amino or R3 is propargyl substituted with phenyl or heteroaryl as defined above, R4 is alkyl, alkenyl-CH2— or alkynyl-CH2—, cycloalkyl or cycloalkylalkyl, in their various isomeric forms, separate or as mixtures, and also their salts, their p
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: January 11, 2005
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacqué, Antony Bigot, Youssef El Ahmad, Jean-Luc Malleron, Serge Mignani, Baptiste Ronan, Michel Tabart, Fabrice Viviani
  • Patent number: 6806277
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) in which: R1 is NH2, alkylamino, dialkylamino, hydroxyamino, alkyl(alkyloxy)amino or alkyloxyamino, R2 is a carboxyl, carboxymethyl or hydroxymethyl radical, R3 is alkyl (1 to 6C) substituted by phenylthio which can itself carry 1 to 3 substituents selected from halogen, OH, alkyl, alkyloxy, CF3, OCF3, COOH, alkyloxycarbonyl, CN and NH2, by cycloalkylthio (3 to 7 members) or by heteroarylthio (5 to 6 members) comprising 1 to 4 heteroatoms selected from N, S and O and optionally itself substituted [by halogen, OH, alkyl, alkyloxy, CF3, OCF3, ═O, COOH, alkyloxycarbonyl, CN or NH2] or R3 is propargyl substituted by phenyl which can itself carry 1 to 3 substituents selected from halogen, OH, alkyl, alkyloxy, CF3, OCF3, COOH, alkyloxycarbonyl, CN and NH2 or substituted by cycloalkyl comprising 3 to 7 members or substituted by 5- to 6-membered heteroaryl comprising 1 to 4 heteroatoms chosen from N, O or S and optionally itself substituted
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: October 19, 2004
    Assignee: Aventis, Pharma S.A.
    Inventors: Eric Bacqué, Jean-Luc Malleron, Serge Mignani, Michel Tabart
  • Patent number: 6602884
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacqué, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stéphane Mutti, Christophe Daubié